Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FROVATRIPTAN SUCCINATE MONOHYDRATE, with a corresponding US DMF Number 22952.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2017, and payment made on March 20, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II